AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: A Consortium of Investigators of Modifiers of BRCA1/2 study
- Fergus J. Couch
- , Olga Sinilnikova
- , Robert A. Vierkant
- , V. Shane Pankratz
- , Zachary S. Fredericksen
- , Dominique Stoppa-Lyonnet
- , Isabelle Coupier
- , David Hughes
- , Agnès Hardouin
- , Pascaline Berthet
- , Susan Peock
- , Margaret Cook
- , Caroline Baynes
- , Shirley Hodgson
- , Patrick J. Morrison
- , Mary E. Porteous
- , Anna Jakubowska
- , Jan Lubinski
- , Jacek Gronwald
- , Amanda B. Spurdle
- Mayo Clinic College of Medicine and Science
- Hospices Civils de LyonCentre Léon Bérard
- Institut national de la santé et de la recherche médicale
- International Agency for Research on Cancer
- Centre François Baclesse
- University of Cambridge
- University of London
- Belfast Health and Social Care Trust
- Western General Hospital
- Pomeranian Medical University in Szczecin
- Queensland Institute of Medical Research
- Peter Maccallum Cancer Centre
- University of Cologne
- Leipzig University
- Technical University of Munich
- Heidelberg University
- University of Münster
- Goethe University Frankfurt
- Memorial Sloan-Kettering Cancer Center
- Samuel Lunenfeld Research Institute
- Cancer Care Ontario
- Leiden University
- Foundation for the Detection of Hereditary Tumors
- Lund University
- National Cancer Institute (NCI)
- University of California at Irvine
- University of Pennsylvania Health System
- Medical University of Vienna
- Dana-Farber Cancer Institute
- Charles University
- Masaryk Memorial Cancer Institute
- H. Lee Moffitt Cancer Center & Research Institute
- Helsinki University Hospital
- German Cancer Research Center
- Université Laval
- Creighton University
- Georgetown University
- Beckman Research Institute of City of Hope
- The University of Chicago
- University of Toronto
- Fox Chase Cancer Center
- University of Texas Southwestern Medical Center
Producción: Contribución a una revista › Artículo › revisión exhaustiva
32
Citas
(Scopus)